ZVRA ZEVRA THERAPEUTICS, INC.companySEC Filings & Insider Trading Activity 2026
Latest ZEVRA THERAPEUTICS, INC. (ZVRA) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 9, 2026, a 10-Q quarterly report filed on May 6, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for ZEVRA THERAPEUTICS, INC. (ZVRA) (SEC CIK 1434647), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on ZEVRA THERAPEUTICS, INC.
Ask AI about ZVRA filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ZVRA positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ZVRA.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of ZEVRA THERAPEUTICS, INC. (ZVRA) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 5, 2026 | - | - | - |
8-K | Jun 5, 2026 | - | - | |
8-K | May 6, 2026 | - | - | |
10-Q | May 6, 2026 | Mar 31, 2026 | - | |
8-K | Mar 16, 2026 | - | Analysis | - |
10-K | Mar 9, 2026 | Dec 31, 2025 | - | |
8-K | Mar 9, 2026 | - | Analysis | - |
8-K | Dec 17, 2025 | - | - | |
8-K | Dec 2, 2025 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 12, 2025 | Jun 30, 2025 | - | |
10-Q | May 13, 2025 | Mar 31, 2025 | - | |
10-K | Mar 12, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 14, 2024 | - | - | |
10-Q | Nov 13, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 14, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Apr 1, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 14, 2024 | - | - | |
SC 13G | Jan 29, 2024 | - | - | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | - | |
10-Q | May 15, 2023 | Mar 31, 2023 | - | |
10-K | Mar 7, 2023 | Dec 31, 2022 | - | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ZVRA share value held by 13F filers tracked by SignalX, by quarter.
- FMR LLC (Fidelity)+818.4K (+34%)
- Dimensional Fund Advisors+400.3K (+259%)
- Goldman Sachs Group+154.4K (+25%)
- State Street Corp+78.6K (+5%)
- Morgan Stanley+34.3K (+3%)
- Millennium Management544.1K (-48%)
- Citadel Advisors LLC144.0K (-14%)
- AQR Capital Management101.2K (-56%)
- Citigroup96.8K (-82%)
- Bank of America Corp81.5K (-56%)
- Franklin Resources+36.8K
- Vanguard Group Inc−3.31M
- JPMorgan Chase & Co−412.3K
- Invesco Ltd−32.2K
Source: 13F-HR filings on SEC EDGAR (aggregated from 134 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ZVRA SEC filings in 2026?
ZEVRA THERAPEUTICS, INC. (ZVRA) has filed a 10-K annual report on March 9, 2026, a 10-Q quarterly report on May 6, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ZVRA file its most recent 10-K annual report?
ZEVRA THERAPEUTICS, INC. (ZVRA) filed its most recent 10-K annual report on March 9, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ZVRA 10-Q quarterly reports?
ZEVRA THERAPEUTICS, INC. (ZVRA)'s most recent 10-Q quarterly report was filed on May 6, 2026. SignalX displays every ZVRA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ZVRA filed recently?
ZEVRA THERAPEUTICS, INC. (ZVRA)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ZVRA insider trading activity (Form 4)?
SignalX aggregates every ZVRA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ZVRA file with the SEC?
ZEVRA THERAPEUTICS, INC. (ZVRA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ZVRA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for ZEVRA THERAPEUTICS, INC. (ZVRA).
What is ZVRA's SEC CIK number?
ZEVRA THERAPEUTICS, INC. (ZVRA)'s SEC CIK (Central Index Key) number is 1434647. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1434647 to look up all ZVRA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of ZEVRA THERAPEUTICS, INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 67+ filings.